The potential role of microRNA (miRNA) in breast cancer treatment has recently been of growing interest.29 The microRNA has been implicated as an early biomarker and potential therapeutic target in oncology research.30 For this reason, our study attempted to explore the role of miRNA in the combination treatment of pyrotinib plus chrysin against HER2-positive breast cancer. This evidence concerns the gene ERBB2 and breast cancer.